Lenacapavir: A Game-Changer in HIV Prevention On September 24, 2025, an unprecedented partnership was announced that promises to transform HIV prevention in low- and middle-income countries (LMICs). Dr. Reddy’s Laboratories has entered into a landmark agreement with Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI to make the injectable HIV prevention tool lenacapavir…